Latest Breaking News On - Markus manns - Page 3 : comparemela.com

Novo Nordisk sees double-digit FY growth; boosts Wegovy supplies to U.S By Reuters

Novo Nordisk doesn't disappoint

The Danish laboratory anticipates another year of robust double-digit growth in sales and operating profit, while beginning to ease restrictions on the supply of its popular weight loss drug, Wegovy..

As Roundup verdicts pile up, Bayer bets big on US appeals courts

Despite more than $4 billion in U.S. jury verdicts over Bayer s Roundup weedkiller, including a $2.25 billion verdict last week, the company so far has shown no willingness to settle, instead betting.

Analysis-As Roundup verdicts pile up, Bayer bets big on US appeals courts

Despite more than $4 billion in U.S. jury verdicts over Bayer's Roundup weedkiller, including a $2.25 billion verdict last week, the company so far has shown no willingness to settle, instead betting that it can greatly reduce, or wipe out, its liability through legal appeals. The strategy means the German pharmaceutical and biotechnology company could face further trials and hefty verdicts for years to come as its appeals work their way through U.S. courts. At least 10 trials are expected this year in state courts around the United States, and close to 50,000 Roundup lawsuits are currently pending.

Bayer's billions in Roundup verdicts increase pressure for new legal strategy